Critically ill COVID-19 patients unlikely to benefit from convalescent plasma, early results from UK trial show
Convalescent plasma has no benefit for patients with COVID-19 who are severely ill and in intensive care, according to early findings from the ‘Randomised, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia’ trial.
Source: pharmaceutical-journal.com